Rocket Doctor AI (TSE:AIDR)
:AIDR
Want to see TSE:AIDR full AI Analyst Report?
AIDR Stock Chart & Stats
C$0.59
--
Market closed
C$0.59
--
Day’s Range― - ―
52-Week RangeC$0.34 - C$0.98
Previous CloseN/A
VolumeN/A
Average Volume (3M)175.17K
Market Cap
C$68.43M
Enterprise ValueC$60.25M
Total Cash (Recent Filing)C$117.59K
Total Debt (Recent Filing)C$613.46K
Price to Earnings (P/E)―
Beta0.81
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding96,376,160
10 Day Avg. Volume215,584
30 Day Avg. Volume175,170
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)30.15
Price to Sales (P/S)2175.03
P/FCF Ratio-5.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$1.86Price Target Upside215.25% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.07
Revenue Forecast (FY)C$4.79M
Bulls Say, Bears Say
Bulls Say
Low LeverageLow debt-to-equity (~0.19) provides durable financial flexibility, reducing interest burden and preserving borrowing capacity. This structural advantage helps the company withstand execution risk while pursuing product rollouts or M&A without immediate refinancing pressure.
Strategic Partnerships & FundingAccess agreements covering ~13M members, a $2M NIH grant and an acquisition expand distribution, non-dilutive funding, and capabilities. Structurally, these moves broaden addressable market and build durable go-to-market channels that can support scaled revenue if execution follows.
Positive Gross ProfitPositive gross profit in 2024 indicates the platform can cover variable costs on delivered services, implying unit economics that can support sustainable margins as revenue scales. This is a fundamental building block for eventual profitability if fixed-cost growth is controlled.
Bears Say
Severe Cash BurnAccelerating cash burn (-$4.44M in 2024 vs -$0.74M in 2023) creates a structural funding risk over the medium term. Persistent outflows force management to secure capital, potentially diluting shareholders and diverting focus from long-term product and market development.
Tiny Revenue Base Vs Large LossesA 2024 revenue base of ~11k versus EBIT losses of -$6.1M shows the company is far from scale. Structurally, costs are materially ahead of demand, making sustained operating leverage unlikely without clear, durable revenue growth and execution on commercialization.
Equity Volatility / Balance Sheet StabilityHistorical negative equity and volatility signal prior dilution/accumulated losses, which can impair credibility with partners and lenders. Over the medium term this raises concerns about balance-sheet resilience and the company’s ability to fund scaling without recurring external support.
Rocket Doctor AI News
AIDR FAQ
What was Rocket Doctor AI’s price range in the past 12 months?
Rocket Doctor AI lowest stock price was C$0.34 and its highest was C$0.98 in the past 12 months.
What is Rocket Doctor AI’s market cap?
Rocket Doctor AI’s market cap is C$68.43M.
When is Rocket Doctor AI’s upcoming earnings report date?
Rocket Doctor AI’s upcoming earnings report date is Aug 27, 2026 which is in 75 days.
How were Rocket Doctor AI’s earnings last quarter?
Currently, no data Available
Is Rocket Doctor AI overvalued?
According to Wall Street analysts Rocket Doctor AI’s price is currently Undervalued.
Does Rocket Doctor AI pay dividends?
Rocket Doctor AI does not currently pay dividends.
What is Rocket Doctor AI’s EPS estimate?
Rocket Doctor AI’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rocket Doctor AI have?
Rocket Doctor AI has 96,376,160 shares outstanding.
What happened to Rocket Doctor AI’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Rocket Doctor AI?
Currently, no hedge funds are holding shares in TSE:AIDR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rocket Doctor AI
Rocket Doctor AI Inc., based in Vancouver, Canada, specializes in delivering personalized healthcare information services across the Canadian market. The company develops a mobile application crafted to help users assess their symptoms and effectively manage their health issues, concerns, and ongoing wellness journey. This sophisticated digital health platform also functions as an insightful assessment tool, offering valuable health analytics. Furthermore, Rocket Doctor AI Inc. provides a range of additional solutions, including medical education resources, tools for medical clinics, expert clinical advisory services, and a comprehensive healthcare information hub. Established in 2018, the company was formerly known as Treatment.com AI Inc. and is slated to officially adopt the name Rocket Doctor AI Inc. in August 2025.
AIDR Stock 12 Month Forecast
Average Price Target
C$1.86
▲(215.25% Upside)
Technical Analysis
Diagnos
―
Vitalhub
―
nDatalyze Corp
―
UniDoc Health Corp
―
DiagnaMed Holdings Corp.
―